MyLabReady Platform
Syndromic Infection Testing (Multiplex Pathogen Detection)
Key Facts
About Vax-Immune
Vax-Immune (LabReady) is pioneering a disruptive point-of-need diagnostic platform that combines rugged, portable hardware, multiplex qPCR assays, and onboard AI verification. Its flagship product, MyLabReady, aims to detect up to five pathogens in approximately 15 minutes without requiring a lab, refrigeration, or specialized technical expertise, targeting markets from clinics to farms. The company is currently in the development and regulatory approval stage, positioning itself to address critical gaps in rapid, accurate diagnostic testing across multiple sectors. Its business model appears focused on diagnostics, with a 'no upfront costs' strategy suggesting a reagent/consumable or subscription-based revenue model.
View full company profile